Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2026)
Cogent Biosciences (COGT) recorded quarterly Other Non Operating Income of -$140000.0 in Q1 2026, down 2233.33% quarter-over-quarter from -$6000.0 in Q4 2025, and down 2700.0% on a YoY basis from $5384.6 in Q1 2025.
Cogent Biosciences (COGT) Other Non Operating Income (2017 - 2026) Analysis & Trends
Cogent Biosciences' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$140000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 2700.0% year-over-year to -$140000.0; the TTM figure through Mar 2026 stood at -$155000.0 (down 3775.0% YoY), while the FY2025 annual figure was -$20000.0, changed N/A from the prior year.
- Other Non Operating Income was -$140000.0 for Q1 2026 at Cogent Biosciences, down from -$6000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $682000.0 in Q1 2023 to a low of -$950000.0 in Q4 2023.
- Historically, Other Non Operating Income has averaged $130562.5 across 5 years, with a median of $0.0 in 2024.
- The sharpest annual moves came in 2024 and 2026: Other Non Operating Income surged 95.37% in 2024, then sank 2700.0% in 2026.
- A 5-year view of Other Non Operating Income shows it stood at $657000.0 in 2022, then sank by 244.6% to -$950000.0 in 2023, then soared by 95.37% to -$44000.0 in 2024, then surged by 86.36% to -$6000.0 in 2025, then slumped by 2233.33% to -$140000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$140000.0 (Q1 2026), -$6000.0 (Q4 2025), and -$3000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Cogent Biosciences | 5.19 Bn | 4.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -44,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -950,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 682,000.00 |
| Dec 31, 2022 | 657,000.00 |
| Sep 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 656,000.00 |
| Mar 31, 2022 | 677,000.00 |
| Dec 31, 2021 | 621,000.00 |
| Sep 30, 2021 | 620,000.00 |
| Jun 30, 2021 | 623,000.00 |
| Mar 31, 2021 | 604,000.00 |